{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:00:50Z","timestamp":1780441250511,"version":"3.54.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"DOI":"10.1093\/cid\/ciaf508","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T11:57:51Z","timestamp":1757678271000},"page":"e494-e496","source":"Crossref","is-referenced-by-count":1,"title":["Is Empirical Antifungal Therapy the Next Path Forward in Patients With Influenza-Associated ARDS?"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9871-636X","authenticated-orcid":false,"given":"Florian","family":"Reizine","sequence":"first","affiliation":[{"name":"Centre Hospitalier de Vannes, Service de R\u00e9animation Polyvalente , Vannes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Gangneux","sequence":"additional","affiliation":[{"name":"European Excellence Center for Medical Mycology (ECMM EC), Laboratoire de Parasitologie-Mycologie, CHU Rennes, Centre National de R\u00e9f\u00e9rence des Mycoses et Antifongiques LA-AspC Aspergilloses chroniques , Rennes ,","place":["France"]},{"name":"Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Sant\u00e9 Environnement Travail)\u2014UMR_S 1085 , Rennes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"2026031619531581000_ciaf508-B1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmj.1.4757.523","article-title":"Pulmonary aspergillosis following post-influenzal bronchopneumonia treated with antibiotics","volume":"1","author":"Abbott","year":"1952","journal-title":"Br Med J"},{"key":"2026031619531581000_ciaf508-B2","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","article-title":"Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study","volume":"38","author":"Wauters","year":"2012","journal-title":"Intensive Care Med"},{"key":"2026031619531581000_ciaf508-B3","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"},{"key":"2026031619531581000_ciaf508-B4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2026031619531581000_ciaf508-B5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1164\/rccm.201910-1931OC","article-title":"Invasive tracheobronchial aspergillosis in critically ill patients with severe influenza. A clinical trial","volume":"202","author":"Nyga","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026031619531581000_ciaf508-B6","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","article-title":"Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients","volume":"12","author":"Feys","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2026031619531581000_ciaf508-B7","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S2213-2600(22)00259-4","article-title":"Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study","volume":"10","author":"Feys","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2026031619531581000_ciaf508-B8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00134-021-06431-0","article-title":"Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial","volume":"47","author":"Vanderbeke","year":"2021","journal-title":"Intensive Care Med"},{"key":"2026031619531581000_ciaf508-B9","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"2026031619531581000_ciaf508-B10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2026031619531581000_ciaf508-B11","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med"},{"key":"2026031619531581000_ciaf508-B12","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciy859","article-title":"Voriconazole resistance and mortality in invasive aspergillosis: a multicenter retrospective cohort study","volume":"68","author":"Lestrade","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026031619531581000_ciaf508-B13","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"2026031619531581000_ciaf508-B14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","article-title":"Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial","volume":"397","author":"Maertens","year":"2021","journal-title":"Lancet"},{"key":"2026031619531581000_ciaf508-B15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00134-024-07767-z","article-title":"A multivariable prediction model for invasive pulmonary aspergillosis in immunocompromised patients with acute respiratory failure (IPA-GRRR-OH score)","volume":"51","author":"Friol","year":"2025","journal-title":"Intensive Care Med"},{"key":"2026031619531581000_ciaf508-B16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13613-023-01199-6","article-title":"Prediction of pulmonary aspergillosis in patients with ventilator-associated pneumonia","volume":"13","author":"Massart","year":"2023","journal-title":"Ann Intensive Care"},{"key":"2026031619531581000_ciaf508-B17","doi-asserted-by":"crossref","first-page":"e70023","DOI":"10.1111\/myc.70023","article-title":"Posaconazole for prevention of COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a European Multicentre Case-Control Study (POSACOVID)","volume":"68","author":"Prattes","year":"2025","journal-title":"Mycoses"},{"key":"2026031619531581000_ciaf508-B18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00134-024-07542-0","article-title":"Antifungal prophylaxis of COVID-19 associated pulmonary aspergillosis in ventilated patients: one solution does not fit all","volume":"50","author":"Prattes","year":"2024","journal-title":"Intensive Care Med"},{"key":"2026031619531581000_ciaf508-B19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"key":"2026031619531581000_ciaf508-B20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00134-025-07793-5","article-title":"Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units\u2014the SAFE-ICU study","volume":"51","author":"Roberts","year":"2025","journal-title":"Intensive Care Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf508\/64275933\/ciaf508.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/3\/e494\/64275933\/ciaf508.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/3\/e494\/64275933\/ciaf508.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:53:25Z","timestamp":1773705205000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/3\/e494\/8254616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9,15]]},"published-print":{"date-parts":[[2026,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf508","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,15]]},"published":{"date-parts":[[2025,9,15]]}}}